Actinium Pharmaceuticals's total assets for Q1 2026 were $45.44M, a decrease of -12.24% from the previous quarter. ATNM total liabilities were $43.13M for the fiscal quarter, a -1.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.